BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 14690616)

  • 1. The proteomics bottleneck: strategies for preliminary validation of potential biomarkers and drug targets.
    Bodovitz S; Joos T
    Trends Biotechnol; 2004 Jan; 22(1):4-7. PubMed ID: 14690616
    [No Abstract]   [Full Text] [Related]  

  • 2. In biomarkers we trust?
    Baker M
    Nat Biotechnol; 2005 Mar; 23(3):297-304. PubMed ID: 15765081
    [No Abstract]   [Full Text] [Related]  

  • 3. Valid data from large-scale proteomics studies.
    Chamrad D; Meyer HE
    Nat Methods; 2005 Sep; 2(9):647-8. PubMed ID: 16118632
    [No Abstract]   [Full Text] [Related]  

  • 4. Promises of biomarkers in drug development--a reality check.
    Marrer E; Dieterle F
    Chem Biol Drug Des; 2007 Jun; 69(6):381-94. PubMed ID: 17581232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics in neurosciences.
    Drabik A; Bierczynska-Krzysik A; Bodzon-Kulakowska A; Suder P; Kotlinska J; Silberring J
    Mass Spectrom Rev; 2007; 26(3):432-50. PubMed ID: 17405153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Finding time for allosteric interactions.
    Wainer IW
    Nat Biotechnol; 2004 Nov; 22(11):1376-7. PubMed ID: 15529160
    [No Abstract]   [Full Text] [Related]  

  • 7. Redesigner drugs.
    Dove A
    Nat Biotechnol; 2004 Aug; 22(8):953-7. PubMed ID: 15286643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics in 2005/2006: developments, applications and challenges.
    Smith JC; Lambert JP; Elisma F; Figeys D
    Anal Chem; 2007 Jun; 79(12):4325-43. PubMed ID: 17477510
    [No Abstract]   [Full Text] [Related]  

  • 9. Latest developments in sample treatment for 18O-isotopic labeling for proteomics mass spectrometry-based approaches: a critical review.
    Capelo JL; Carreira RJ; Fernandes L; Lodeiro C; Santos HM; Simal-Gandara J
    Talanta; 2010 Feb; 80(4):1476-86. PubMed ID: 20082805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers: a valuable tool in clinical research and medical practice.
    Carini C
    IDrugs; 2007 Jun; 10(6):395-8. PubMed ID: 17642003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian plasma membrane proteins as potential biomarkers and drug targets.
    Rucevic M; Hixson D; Josic D
    Electrophoresis; 2011 Jun; 32(13):1549-64. PubMed ID: 21706493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In the pursuit of industrial proteomics.
    Mitchell P
    Nat Biotechnol; 2003 Mar; 21(3):233-7. PubMed ID: 12610565
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative evaluation of mass spectrometry platforms used in large-scale proteomics investigations.
    Elias JE; Haas W; Faherty BK; Gygi SP
    Nat Methods; 2005 Sep; 2(9):667-75. PubMed ID: 16118637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The promising future of proteomics in sarcoidosis.
    Agostini C; Facco M
    Am J Respir Crit Care Med; 2006 May; 173(10):1053-4. PubMed ID: 16679442
    [No Abstract]   [Full Text] [Related]  

  • 15. Introducing the CPL/MUW proteome database: interpretation of human liver and liver cancer proteome profiles by referring to isolated primary cells.
    Wimmer H; Gundacker NC; Griss J; Haudek VJ; Stättner S; Mohr T; Zwickl H; Paulitschke V; Baron DM; Trittner W; Kubicek M; Bayer E; Slany A; Gerner C
    Electrophoresis; 2009 Jun; 30(12):2076-89. PubMed ID: 19582709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolytic 18O-labeling strategies for quantitative proteomics.
    Miyagi M; Rao KC
    Mass Spectrom Rev; 2007; 26(1):121-36. PubMed ID: 17086517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Looking for Thom's biomarkers with proteomics.
    Drukier AK; Grigoriev I; Brown LR; Tomaszewski JE; Sainsbury R; Godovac-Zimmermann J
    J Proteome Res; 2006 Aug; 5(8):2046-8. PubMed ID: 16889429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of proteomics in biotechnology--microbial proteomics.
    Josic D; Kovac S
    Biotechnol J; 2008 Apr; 3(4):496-509. PubMed ID: 18320565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced detectability in proteome studies.
    Sriyam S; Sinchaikul S; Tantipaiboonwong P; Tzao C; Phutrakul S; Chen ST
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):91-104. PubMed ID: 17140866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of anti-infective targets through comparative proteomics.
    Burchmore R
    Expert Rev Anti Infect Ther; 2006 Apr; 4(2):163-5. PubMed ID: 16597196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.